Next Article in Journal
Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
Next Article in Special Issue
Loss of Response to Long-Term Infliximab Therapy in Children with Crohn’s Disease
Previous Article in Journal
FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver
Previous Article in Special Issue
Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production
Pharmaceuticals 2013, 6(5), 681-688; doi:10.3390/ph6050681

Notes on Article Versions

NoteDate
Article Published14 May 2013 12:14 CEST
article pdf uploaded.14 May 2013 12:18 CEST
article word file uploaded.14 May 2013 12:18 CEST
article files uploaded.14 May 2013 12:18 CEST
article files uploaded.14 May 2013 12:18 CEST
abstract image uploaded.14 May 2013 12:19 CEST
article xml file uploaded13 September 2013 17:19 CEST
article html file updated13 September 2013 17:19 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert